208 related articles for article (PubMed ID: 23715514)
1. Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer.
Wang XY; Yu H; Linnoila RI; Li L; Li D; Mo B; Okano H; Penalva LO; Glazer RI
Oncotarget; 2013 May; 4(5):739-50. PubMed ID: 23715514
[TBL] [Abstract][Full Text] [Related]
2. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival.
Wang XY; Penalva LO; Yuan H; Linnoila RI; Lu J; Okano H; Glazer RI
Mol Cancer; 2010 Aug; 9():221. PubMed ID: 20727204
[TBL] [Abstract][Full Text] [Related]
3. Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway.
Lang Y; Kong X; He C; Wang F; Liu B; Zhang S; Ning J; Zhu K; Xu S
Cell Physiol Biochem; 2017; 44(2):455-466. PubMed ID: 29141252
[TBL] [Abstract][Full Text] [Related]
4. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
[TBL] [Abstract][Full Text] [Related]
5. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer.
Cui F; Wang J; Chen D; Chen YJ
Oncol Rep; 2011 Mar; 25(3):701-8. PubMed ID: 21174061
[TBL] [Abstract][Full Text] [Related]
6. Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways.
Wang XY; Yin Y; Yuan H; Sakamaki T; Okano H; Glazer RI
Mol Cell Biol; 2008 Jun; 28(11):3589-99. PubMed ID: 18362162
[TBL] [Abstract][Full Text] [Related]
7. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.
Muto J; Imai T; Ogawa D; Nishimoto Y; Okada Y; Mabuchi Y; Kawase T; Iwanami A; Mischel PS; Saya H; Yoshida K; Matsuzaki Y; Okano H
PLoS One; 2012; 7(3):e33431. PubMed ID: 22428049
[TBL] [Abstract][Full Text] [Related]
8. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
9. Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.
Gong P; Wang Y; Gao Y; Gao M; Liu L; Qu P; Jin X; Gao Q
Hum Pathol; 2017 Jul; 65():53-61. PubMed ID: 28088346
[TBL] [Abstract][Full Text] [Related]
10. WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma.
Abbaszadegan MR; Riahi A; Forghanifard MM; Moghbeli M
Cell Mol Biol Lett; 2018; 23():42. PubMed ID: 30202417
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.
Vo DT; Qiao M; Smith AD; Burns SC; Brenner AJ; Penalva LO
RNA Biol; 2011; 8(5):817-28. PubMed ID: 21881409
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological sex- related relevance of musashi1 mRNA expression in esophageal squamous cell carcinoma patients.
Moghbeli M; Forghanifard MM; Aarabi A; Mansourian A; Abbaszadegan MR
Pathol Oncol Res; 2014 Apr; 20(2):427-33. PubMed ID: 24163304
[TBL] [Abstract][Full Text] [Related]
13. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.
Sanchez-Diaz PC; Burton TL; Burns SC; Hung JY; Penalva LO
BMC Cancer; 2008 Sep; 8():280. PubMed ID: 18826648
[TBL] [Abstract][Full Text] [Related]
14. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b.
Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Ghaedi K
BMC Mol Cell Biol; 2021 Feb; 22(1):10. PubMed ID: 33541259
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
17. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
Roudi R; Korourian A; Shariftabrizi A; Madjd Z
Cancer Invest; 2015; 33(7):294-302. PubMed ID: 26046383
[TBL] [Abstract][Full Text] [Related]
18. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
[TBL] [Abstract][Full Text] [Related]
19. Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells.
Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Gure AO; Ghaedi K
Stem Cell Res Ther; 2020 May; 11(1):193. PubMed ID: 32448364
[TBL] [Abstract][Full Text] [Related]
20. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.
Kubo T; Takigawa N; Osawa M; Harada D; Ninomiya T; Ochi N; Ichihara E; Yamane H; Tanimoto M; Kiura K
Cancer Sci; 2013 Jan; 104(1):78-84. PubMed ID: 23066953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
